The best place for a Mounjaro injection, and what the guidance actually says

What the licensed prescribing information tells you to do, and why rotation is the real answer

The Mounjaro SmPC, and the NHS patient information that follows it, specify three subcutaneous injection sites: the abdomen (belly), the front or outer thigh, and the outer area of the upper arm. All three are considered equally appropriate from a pharmacokinetic standpoint, tirzepatide's absorption profile across these sites is consistent enough that the manufacturer does not rank one above the others. The practical guidance our prescribers pass on most weeks is this: the site matters less than the habit of changing it. Injecting into exactly the same spot repeatedly can cause lipohypertrophy, a localised thickening of fatty tissue that slows absorption and reduces how reliably the medicine works.

Within each site, aim to move a few centimetres from the previous injection, think of working around a clock face rather than returning to the same point. The abdomen is the site many people start with because it is easy to reach and offers a broad area to rotate across; keep injections at least 5 cm away from the navel. The thigh is a practical alternative if the abdomen feels uncomfortable. If you are weighing up which site suits your routine best, our guide to where is the best place to inject Mounjaro walks through the considerations for each location in plain terms. Upper arm injections are straightforward if someone else is helping; self-injecting into the upper arm is possible but takes practice. For a detailed visual guide to picking specific spots within each site, the guide to the best place to inject Mounjaro walks through each location step by step.

One rule applies to all three sites: never inject into skin that is red, tender, bruised, scarred or hardened from a previous reaction. That tissue absorbs medicine unpredictably and raises the risk of further irritation.

Technique: how depth and preparation affect what happens under the skin

Mounjaro is a subcutaneous injection, it goes into the layer of fatty tissue just beneath the skin, not into muscle. The KwikPen is designed to deliver the correct needle depth automatically, so you do not need to pinch the skin the way older insulin devices required; the NHS guidance confirms this. What you do before and after the injection still matters. Cleaning the chosen site with an alcohol swab and letting it dry fully (wet skin can sting and increase the risk of a small skin reaction) takes about 30 seconds and is worth the pause. Some people find that removing the pen from the fridge 20–30 minutes before injecting reduces the brief stinging sensation that cold solution can cause, check the SmPC for exactly how long the pen can safely remain at room temperature, since the window is specific and should not be guessed at.

After injecting, hold the pen in place for the number of seconds the instructions specify, then withdraw it smoothly. Do not rub the site afterwards; rubbing does not speed absorption and can irritate the skin. Used pens should be disposed of in a proper sharps container, a 1-litre sharps bin is an inexpensive, legally compliant way to manage this at home. For people who want to understand how injection technique fits into the broader question of getting the best from treatment, the evidence on injection technique and results covers that in more detail.

Site reactions: what is normal and what needs attention

Mild redness, slight swelling or itching at the injection site in the hours after each dose is a recognised and common response. The NHS tirzepatide information page lists injection-site reactions among the frequently reported effects of treatment, alongside the more familiar gastrointestinal symptoms like nausea and indigestion. For most people the reaction is small and resolves within a day or two. Rotating sites, as described above, is the single most effective way to reduce their frequency.

Some signs warrant a call to your prescriber rather than a wait-and-see approach: a lump or thickening that does not flatten over several weeks, spreading redness that goes beyond the immediate injection area, or any reaction that appears to be getting worse rather than better. Our guide to managing Mounjaro injection site reactions covers the spectrum of reactions in practical detail. If a dose is making site reactions worse, that conversation with your prescriber is worthwhile before your next injection, never adjust timing or dose on your own. For a broader picture of how tirzepatide is administered week to week, the Mounjaro injection overview pulls together device, timing and storage information in one place.

Cost can come up as a background concern when people are thinking through whether to start treatment. If that is on your mind, the page covering what Mounjaro costs through UK private providers sets out the honest market picture. The right place to start, though, is a clinical conversation: understanding your injection sites is one part of it, and a prescriber's assessment covers everything else. Speak to our prescribers through a free consultation if you would like to explore whether Mounjaro is appropriate for you.